ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 133 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $645,572 | -18.6% | 195,037 | -0.6% | 0.00% | – |
Q1 2024 | $792,906 | +17.3% | 196,264 | -11.4% | 0.00% | – |
Q4 2023 | $675,773 | +6.2% | 221,565 | +4.5% | 0.00% | – |
Q3 2023 | $636,333 | -19.2% | 212,111 | +0.8% | 0.00% | – |
Q2 2023 | $787,383 | +8.4% | 210,530 | -2.9% | 0.00% | – |
Q1 2023 | $726,193 | +2.1% | 216,774 | +46.5% | 0.00% | – |
Q4 2022 | $711,538 | +7.2% | 147,929 | +26.8% | 0.00% | – |
Q3 2022 | $664,000 | -22.8% | 116,640 | -3.7% | 0.00% | – |
Q2 2022 | $860,000 | +13.5% | 121,132 | +15.3% | 0.00% | – |
Q1 2022 | $758,000 | +155.2% | 105,018 | +215.4% | 0.00% | – |
Q4 2021 | $297,000 | -97.3% | 33,293 | -89.5% | 0.00% | -100.0% |
Q3 2021 | $11,134,000 | +2279.1% | 317,579 | +1356.9% | 0.00% | – |
Q2 2021 | $468,000 | -11.2% | 21,798 | +155.2% | 0.00% | – |
Q1 2021 | $527,000 | – | 8,542 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
CM Management, LLC | 270,000 | $823,500 | 0.66% |
EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
Auour Investments LLC | 177,000 | $670,830 | 0.26% |